Tau protein as neurodegenerative disease research's key target +++

https://www.news-medical.net/whitepaper/20250701/Tau-protein-as-neurodegenerative-disease-researchs-key-target.aspx Tau protein is a microtubule-associated protein, widely present in the central nervous system. It plays a key role in maintaining and regulating the structure and function of neurons. Integrin proteins for targeted drug development https://www.news-medical.net/whitepaper/20250701/Integrin-proteins-for-targeted-drug-development.aspx Pfizer's integrin αvβ6-targeting Antibody-Drug Conjugate (ADC) candidate, Sigvotatug Vedotin (PF-08046047, also known as SGN-B6A), has progressed to Phase III clinical trials for PD-L1 high-expressing NSCLC. Recombinant factor C for pharmaceutical manufacturing https://www.news-medical.net/whitepaper/20250701/Recombinant-factor-C-for-pharmaceutical-manufacturing.aspx Ensuring the safety and quality of pharmaceuticals, such as blood products, vaccines, recombinant proteins, and monoclonal antibodies, is essential. Endotoxins act as a hidden ‘time bomb’ in these pharmaceuticals, threatening product safety and indicating production flaws.